A detailed history of Sargent Investment Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Sargent Investment Group, LLC holds 1,776 shares of NVO stock, worth $253,932. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,776
Previous 2,776 36.02%
Holding current value
$253,932
Previous $287,000 20.56%
% of portfolio
0.05%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$102.11 - $135.92 $102,110 - $135,920
-1,000 Reduced 36.02%
1,776 $228,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $134,227 - $294,521
1,476 Added 113.54%
2,776 $252,000
Q1 2023

May 02, 2023

SELL
$132.34 - $159.14 $26,468 - $31,827
-200 Reduced 13.33%
1,300 $206,000
Q4 2022

Jan 31, 2023

BUY
$102.55 - $135.33 $153,825 - $202,995
1,500 New
1,500 $202,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $323B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Sargent Investment Group, LLC Portfolio

Follow Sargent Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Investment Group, LLC with notifications on news.